Thymulin (FTS-Zn) induced in vitro modulation of T cell subsets markers on lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients
- 1 January 1984
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 6 (4), 381-388
- https://doi.org/10.1016/0192-0561(84)90058-4
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 1982
- IMPROVEMENT OF CELLULAR IMMUNITY AND IgA PRODUCTION IN IMMUNODEFICIENT CHILDREN AFTER TREATMENT WITH SYNTHETIC SERUM THYMIC FACTOR (FTS)The Lancet, 1982
- THYMOPOIETIN IN RHEUMATOID ARTHRITISRheumatology, 1982
- Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid ?-naphthyl esterase stainingRheumatology International, 1982
- Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agentsInternational Journal of Immunopharmacology, 1981
- THYMOSIN ADMINISTRATION IN AUTOIMMUNE DISORDERS1981
- Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.Journal of Clinical Investigation, 1980
- A Monoclonal Antibody with Selective Reactivity with Functionally Mature Human Thymocytes and All Peripheral Human T CellsThe Journal of Immunology, 1979
- INVITRO EFFECT OF THYMOSIN ON T-LYMPHOCYTE ROSETTE FORMATION IN RHEUMATIC DISEASES1976